We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

2 hedge funds and large institutions have $1.37M invested in Cardiovascular Systems, Inc. in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 1502 (-148)

100% less capital invested

Capital invested by funds: $767M → $1.37M (-$765M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 148

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-148
Holders Change %
-98.67%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
1
Closed
148
Calls
Puts
Net Calls
Net Calls Change

CSII Hedge Fund Activity: Q2 2023 in Review

2 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2023, worth a combined $1.37M — down 100% from $767M a quarter earlier.

Sellers outnumbered buyers: 148 funds closed out of CSII and 0 opened new positions — a net loss of 148 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $143M sold.

  • 2 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2023, down from 150 in Q1 2023.
  • Funds reported $1.37M of Cardiovascular Systems, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Cardiovascular Systems, Inc. positions in Q2 2023 and 148 closed out, a net change of -148 holders.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2023 was BlackRock, an estimated $143M sold.

Based on aggregated 13F filings for Q2 2023.